Yvette Anderson MPS[/caption]
Naloxone nasal spray added to the PBS
With increasing overdose deaths from both prescription opioids and heroin, naloxone nasal spray – now listed on the Pharmaceutical Benefits Scheme – is a...
Responding to concerns about paracetamol use in pregnancy
As US regulators flag new warnings on paracetamol use, the TGA and Australian experts have weighed in on what the evidence shows.
Pharmacists and Australia’s COVID-19 vaccination policy
Pharmacies are likely to play a role in COVID-19 vaccination, and people at increased risk of exposure, including health and aged care workers, will be among the first to receive a vaccine.
Importation of nicotine e-cigarettes to be banned
From next Wednesday, proposed customs regulations will prohibit the importation of e-cigarettes containing vaporiser nicotine (nicotine liquids and salts) and nicotine-containing refills.
First vaccine appointments for 5–11 years run smoothly, amid cancellations
Community pharmacists were some of the first to vaccinate children aged 5–11 against COVID-19 this week.
Making a difference in mental health
One in six Australians receive a mental health-related prescription each year.1 Almost half the population is set to experience a mental health condition in...
